Filters

 

Resource Type
Metrion Biosciences listed in The Sunday Times 100 Tech, as one of Britain's fastest-growing private technology companies

The inaugural feature, published 19th January, highlights the UK’s fastest-growing private companies developing or selling unique, proprietary technologies, and is backed by Singer Capital Markets, HSBC Innovation Banking and BDO.

Read More
Metrion Biosciences appoints Lee Patterson as CEO

An experienced life sciences and CRO executive, Lee will guide the Company as it seeks to execute an ambitious growth strategy, enhancing its specialist services and expanding further in key global markets. He succeeds Dr Andrew Southan, who has decided to step down as CEO after five years in the post.

Read More
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Read More
Metrion Biosciences enhances high-throughput screening services with access to Enamine compound libraries
Read More
Metrion Biosciences strengthens team with 3 key appointments
Read More
Metrion Biosciences closes £3.7m new equity financing
Read More
Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Testing Service
Read More
Metrion Biosciences expands senior leadership team with appointments of Dr Robert Kirby as COO and Dr Edward Stevens as CSO
Read More
Metrion Biosciences appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to strengthen US Operations
Read More
Metrion Biosciences and the KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
Read More
1 2 3 5
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram